Aquestive Therapeutics
Carla Valenti Buan has extensive experience in pharmaceutical product development and project management, currently serving as Clinical Project Manager and Product Development Manager at Aquestive Therapeutics since July 2016. Prior to this, Carla held the position of Product Development Manager at MonoSol Rx, LLC, and spent nearly a decade at GSK Consumer Healthcare PTE LTD, where roles included R&D Pipeline Manager and Principal Scientist focusing on pain management. Earlier career experiences include significant roles at GlaxoSmithKline Consumer Healthcare and FMC BioPolymer, emphasizing formulation science and drug delivery solutions. Carla holds a Bachelor’s Degree in Pharmacy from the University of the Sciences in Philadelphia and a Certificate in Project Management from Stevens Institute of Technology.
Aquestive Therapeutics
Aquestive Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on the development of treatments for diseases related to the central nervous system (CNS). Its CNS programs consist of a pipeline of products that include Libervant, Sympazan, and AQST-117.